1. Chen, Tzu-Ju, Tian, Yu-Feng, Chou, Chia-Lin, Li, Chien-Feng, Lai, Hong-Yue. 2021. High SPINK4 Expression Predicts Poor Outcomes among Rectal Cancer Patients Receiving CCRT. In Current oncology (Toronto, Ont.), 28, 2373-2384. doi:10.3390/curroncol28040218. https://pubmed.ncbi.nlm.nih.gov/34202399/
2. Yang, Xiaodi, Jiang, Sen, Yuan, Zhen, Luo, Jing, Ye, Tao. 2024. SPINK4 modulates inhibition of glycolysis against colorectal cancer progression. In Biomolecules & biomedicine, 24, 1571-1585. doi:10.17305/bb.2024.10338. https://pubmed.ncbi.nlm.nih.gov/38747892/
3. Buijs, Jeroen T, van Beijnum, Robin, Anijs, Rayna J S, Cannegieter, Suzanne C, Versteeg, Henri H. 2023. The association of tumor-expressed REG4, SPINK4 and alpha-1 antitrypsin with cancer-associated thrombosis in colorectal cancer. In Journal of thrombosis and thrombolysis, 57, 370-380. doi:10.1007/s11239-023-02907-6. https://pubmed.ncbi.nlm.nih.gov/38066386/
4. Wang, Xiaojie, Yu, Qian, Ghareeb, Waleed M, Liu, Jin, Chi, Pan. 2019. Downregulated SPINK4 is associated with poor survival in colorectal cancer. In BMC cancer, 19, 1258. doi:10.1186/s12885-019-6484-5. https://pubmed.ncbi.nlm.nih.gov/31888570/
5. Chai, Ruoyang, Zhao, Yajie, Su, Zhengjia, Liang, Wei. 2023. Integrative analysis reveals a four-gene signature for predicting survival and immunotherapy response in colon cancer patients using bulk and single-cell RNA-seq data. In Frontiers in oncology, 13, 1277084. doi:10.3389/fonc.2023.1277084. https://pubmed.ncbi.nlm.nih.gov/38023180/
智鼠故事 
